SDGR in Freefall Yesterday
by bigeasy | March 6, 2021 8:12 am
Imagine my surprise when my limit order for $70 was executed for SDGR.
Any thoughts about the downside? I’m a new subscriber and the content and contributions are great. Thanks, Travis and friends.
Source URL: https://www.stockgumshoe.com/2021/03/microblog-sdgr-in-freefall-yesterday/
In the short term, there’s almost no limit to the downside if sentiment for growth or biotech stories collapses in a real rout. The stock fell mostly because revenue guidance was wildly lower than analysts had expected, revenue is likely to grow unevenly over the next couple years, I expect, and the highest potential projects, the drugs they’re developing on their own, will take years to play out and consume a lot of the cash flow from the software business, so it could be a very bumpy ride.